Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
Nurmohamed
Michael T
MT
Lems
Willem F
WF
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000068579:Celecoxib; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors; D004008:Diclofenac; D004359:Drug Therapy, Combination; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D009853:Omeprazole / Q000627:therapeutic use; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control*; D011720:Pyrazoles; D012307:Risk Factors; D055502:Secondary Prevention; D013449:Sulfonamides
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D000068579:Celecoxib; D009853:Omeprazole